OTC Transdermal Analgesic Patches - Global and China Top Players Market Share and Ranking 2023
According to Research, the global market for OTC Transdermal Analgesic Patches should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China OTC Transdermal Analgesic Patches market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States OTC Transdermal Analgesic Patches market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Pharmacy grew percent to account for percent of the total market sales, and Clinic grew percent.
This report studies and analyses global OTC Transdermal Analgesic Patches status and future trends, helps the client to determine the OTC Transdermal Analgesic Patches market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for OTC Transdermal Analgesic Patches, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global OTC Transdermal Analgesic Patches market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global OTC Transdermal Analgesic Patches sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China OTC Transdermal Analgesic Patches sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global OTC Transdermal Analgesic Patches key consuming regions, consumption quantity, consumption value and demand structure
(5) Global OTC Transdermal Analgesic Patches key producing regions, capacity, production, and year over year growth
(6) OTC Transdermal Analgesic Patches industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Hisamitsu
Mylan
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Actavis
Teikoku Seiyaku
Novartis
Market segment by Type, covers
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Others
Market segment by Application, can be divided into
Pharmacy
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe OTC Transdermal Analgesic Patches product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global OTC Transdermal Analgesic Patches market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China OTC Transdermal Analgesic Patches market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of OTC Transdermal Analgesic Patches, percent & CAGR, 2018-2029
Chapter 5: OTC Transdermal Analgesic Patches industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 OTC Transdermal Analgesic Patches Definition
1.2 Global OTC Transdermal Analgesic Patches Market Size and Forecast
1.2.1 By Consumption Value, Global OTC Transdermal Analgesic Patches Market Size，2018-2029
1.2.2 By Sales Quantity, Global OTC Transdermal Analgesic Patches Market Size，2018-2029
1.2.3 Global OTC Transdermal Analgesic Patches Average Selling Price (ASP)，2018-2029
1.3 China OTC Transdermal Analgesic Patches Market Size and Forecast
1.3.1 By Consumption Value, China OTC Transdermal Analgesic Patches Market Size，2018-2029
1.3.2 By Sales Quantity, China OTC Transdermal Analgesic Patches Market Size，2018-2029
1.3.3 China OTC Transdermal Analgesic Patches Average Selling Price (ASP)， 2018-2029
1.4 Share of China OTC Transdermal Analgesic Patches Market with Respect to the Global Market
1.4.1 By Consumption Value, China OTC Transdermal Analgesic Patches Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China OTC Transdermal Analgesic Patches Market Share in Global, 2018-2029
1.4.3 OTC Transdermal Analgesic Patches Market Size: China VS Global, 2018-2029
1.5 OTC Transdermal Analgesic Patches Market Dynamics
1.5.1 OTC Transdermal Analgesic Patches Market Drivers
1.5.2 OTC Transdermal Analgesic Patches Market Restraints
1.5.3 OTC Transdermal Analgesic Patches Industry Trends
1.5.4 OTC Transdermal Analgesic Patches Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of OTC Transdermal Analgesic Patches, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of OTC Transdermal Analgesic Patches, Global Market Share by Company, 2018-2023
2.3 OTC Transdermal Analgesic Patches Average Selling Price (ASP) by Company, 2018-2023
2.4 Global OTC Transdermal Analgesic Patches Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global OTC Transdermal Analgesic Patches Concentration Ratio
2.6 Global OTC Transdermal Analgesic Patches Mergers & Acquisitions, Expansion Plans
2.7 Global OTC Transdermal Analgesic Patches Manufacturers Product Type
2.8 Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
2.9 OTC Transdermal Analgesic Patches Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of OTC Transdermal Analgesic Patches, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of OTC Transdermal Analgesic Patches, China Market Share by Company, 2018-2023
3.3 China OTC Transdermal Analgesic Patches Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global OTC Transdermal Analgesic Patches Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global OTC Transdermal Analgesic Patches Capacity by Region
4.3 Global OTC Transdermal Analgesic Patches Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global OTC Transdermal Analgesic Patches Production by Region, 2018-2029
4.5 Global OTC Transdermal Analgesic Patches Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 OTC Transdermal Analgesic Patches Industry Chain
5.2 OTC Transdermal Analgesic Patches Upstream Analysis
5.2.1 OTC Transdermal Analgesic Patches Core Raw Materials
5.2.2 Main Manufacturers of OTC Transdermal Analgesic Patches Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 OTC Transdermal Analgesic Patches Production Mode
5.6 OTC Transdermal Analgesic Patches Procurement Model
5.7 OTC Transdermal Analgesic Patches Industry Sales Model and Sales Channels
5.7.1 OTC Transdermal Analgesic Patches Sales Model
5.7.2 OTC Transdermal Analgesic Patches Typical Distributors
6 Sights by Type
6.1 OTC Transdermal Analgesic Patches Classification
6.1.1 Lidocaine Patches
6.1.2 Diclofenac Patches
6.1.3 Indomethacin Patches
6.1.4 Counter-Irritant Patches
6.1.5 Others
6.2 By Type, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029
6.4 By Type, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029
6.5 By Type, Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 OTC Transdermal Analgesic Patches Segment by Application
7.1.1 Pharmacy
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029
7.4 By Application, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029
7.5 By Application, Global OTC Transdermal Analgesic Patches Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029
8.3 By Region, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America OTC Transdermal Analgesic Patches & Forecasts, 2018-2029
8.4.2 By Country, North America OTC Transdermal Analgesic Patches Market Size Market Share
8.5 Europe
8.5.1 Europe OTC Transdermal Analgesic Patches Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe OTC Transdermal Analgesic Patches Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific OTC Transdermal Analgesic Patches Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific OTC Transdermal Analgesic Patches Market Size Market Share
8.7 South America
8.7.1 South America OTC Transdermal Analgesic Patches Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America OTC Transdermal Analgesic Patches Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global OTC Transdermal Analgesic Patches Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029
9.3 By Country, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.4.2 By Type, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.5.2 By Type, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.6.2 By Type, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.7.2 By Type, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.8.2 By Type, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.9.2 By Type, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.10.2 By Type, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa OTC Transdermal Analgesic Patches Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Hisamitsu
10.1.1 Hisamitsu Company Information, Head Office, Market Area, and Industry Position
10.1.2 Hisamitsu OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.1.3 Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Hisamitsu Company Profile and Main Business
10.1.5 Hisamitsu Recent Developments
10.2 Mylan
10.2.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.2.2 Mylan OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.2.3 Mylan OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Mylan Company Profile and Main Business
10.2.5 Mylan Recent Developments
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.3.2 Johnson & Johnson OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Johnson & Johnson Company Profile and Main Business
10.3.5 Johnson & Johnson Recent Developments
10.4 Teva
10.4.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.4.2 Teva OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.4.3 Teva OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Teva Company Profile and Main Business
10.4.5 Teva Recent Developments
10.5 Lingrui
10.5.1 Lingrui Company Information, Head Office, Market Area, and Industry Position
10.5.2 Lingrui OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.5.3 Lingrui OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Lingrui Company Profile and Main Business
10.5.5 Lingrui Recent Developments
10.6 Sanofi
10.6.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sanofi OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.6.3 Sanofi OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sanofi Company Profile and Main Business
10.6.5 Sanofi Recent Developments
10.7 Qizheng
10.7.1 Qizheng Company Information, Head Office, Market Area, and Industry Position
10.7.2 Qizheng OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.7.3 Qizheng OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Qizheng Company Profile and Main Business
10.7.5 Qizheng Recent Developments
10.8 Endo
10.8.1 Endo Company Information, Head Office, Market Area, and Industry Position
10.8.2 Endo OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.8.3 Endo OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Endo Company Profile and Main Business
10.8.5 Endo Recent Developments
10.9 Huarun 999
10.9.1 Huarun 999 Company Information, Head Office, Market Area, and Industry Position
10.9.2 Huarun 999 OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.9.3 Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Huarun 999 Company Profile and Main Business
10.9.5 Huarun 999 Recent Developments
10.10 GSK
10.10.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.10.2 GSK OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.10.3 GSK OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 GSK Company Profile and Main Business
10.10.5 GSK Recent Developments
10.11 Haw Par
10.11.1 Haw Par Company Information, Head Office, Market Area, and Industry Position
10.11.2 Haw Par OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.11.3 Haw Par OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Haw Par Company Profile and Main Business
10.11.5 Haw Par Recent Developments
10.12 Nichiban
10.12.1 Nichiban Company Information, Head Office, Market Area, and Industry Position
10.12.2 Nichiban OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.12.3 Nichiban OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Nichiban Company Profile and Main Business
10.12.5 Nichiban Recent Developments
10.13 Laboratoires Genevrier
10.13.1 Laboratoires Genevrier Company Information, Head Office, Market Area, and Industry Position
10.13.2 Laboratoires Genevrier OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Laboratoires Genevrier Company Profile and Main Business
10.13.5 Laboratoires Genevrier Recent Developments
10.14 BLUE-EMU
10.14.1 BLUE-EMU Company Information, Head Office, Market Area, and Industry Position
10.14.2 BLUE-EMU OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 BLUE-EMU Company Profile and Main Business
10.14.5 BLUE-EMU Recent Developments
10.15 IBSA Group
10.15.1 IBSA Group Company Information, Head Office, Market Area, and Industry Position
10.15.2 IBSA Group OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.15.3 IBSA Group OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 IBSA Group Company Profile and Main Business
10.15.5 IBSA Group Recent Developments
10.16 Pfizer
10.16.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.16.2 Pfizer OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.16.3 Pfizer OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Pfizer Company Profile and Main Business
10.16.5 Pfizer Recent Developments
10.17 Performance Health
10.17.1 Performance Health Company Information, Head Office, Market Area, and Industry Position
10.17.2 Performance Health OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.17.3 Performance Health OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Performance Health Company Profile and Main Business
10.17.5 Performance Health Recent Developments
10.18 Actavis
10.18.1 Actavis Company Information, Head Office, Market Area, and Industry Position
10.18.2 Actavis OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.18.3 Actavis OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Actavis Company Profile and Main Business
10.18.5 Actavis Recent Developments
10.19 Teikoku Seiyaku
10.19.1 Teikoku Seiyaku Company Information, Head Office, Market Area, and Industry Position
10.19.2 Teikoku Seiyaku OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Teikoku Seiyaku Company Profile and Main Business
10.19.5 Teikoku Seiyaku Recent Developments
10.20 Novartis
10.20.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.20.2 Novartis OTC Transdermal Analgesic Patches Models, Specifications, and Application
10.20.3 Novartis OTC Transdermal Analgesic Patches Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Novartis Company Profile and Main Business
10.20.5 Novartis Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. OTC Transdermal Analgesic Patches Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. OTC Transdermal Analgesic Patches Market Restraints
Table 3. OTC Transdermal Analgesic Patches Market Trends
Table 4. OTC Transdermal Analgesic Patches Industry Policy
Table 5. Global OTC Transdermal Analgesic Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global OTC Transdermal Analgesic Patches Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global OTC Transdermal Analgesic Patches Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global OTC Transdermal Analgesic Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global OTC Transdermal Analgesic Patches Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global OTC Transdermal Analgesic Patches Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global OTC Transdermal Analgesic Patches Mergers & Acquisitions, Expansion Plans
Table 12. Global OTC Transdermal Analgesic Patches Manufacturers Product Type
Table 13. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
Table 14. OTC Transdermal Analgesic Patches Capacity of Major Manufacturers and Future Plan
Table 15. China OTC Transdermal Analgesic Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China OTC Transdermal Analgesic Patches Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China OTC Transdermal Analgesic Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global OTC Transdermal Analgesic Patches Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global OTC Transdermal Analgesic Patches Production by Region, 2018-2023, (K Units)
Table 20. Global OTC Transdermal Analgesic Patches Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of OTC Transdermal Analgesic Patches Upstream (Raw Materials)
Table 22. Global OTC Transdermal Analgesic Patches Typical Customers
Table 23. OTC Transdermal Analgesic Patches Typical Distributors
Table 24. By Type, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029
Table 32. By Country, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029
Table 34. Hisamitsu Company Information, Head Office, Market Area, and Industry Position
Table 35. Hisamitsu OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 36. Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Hisamitsu Company Profile and Main Business
Table 38. Hisamitsu Recent Developments
Table 39. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 40. Mylan OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 41. Mylan OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Mylan Company Profile and Main Business
Table 43. Mylan Recent Developments
Table 44. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 45. Johnson & Johnson OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 46. Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Johnson & Johnson Company Profile and Main Business
Table 48. Johnson & Johnson Recent Developments
Table 49. Teva Company Information, Head Office, Market Area, and Industry Position
Table 50. Teva OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 51. Teva OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Company Profile and Main Business
Table 53. Teva Recent Developments
Table 54. Lingrui Company Information, Head Office, Market Area, and Industry Position
Table 55. Lingrui OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 56. Lingrui OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Lingrui Company Profile and Main Business
Table 58. Lingrui Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 60. Sanofi OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 61. Sanofi OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Qizheng Company Information, Head Office, Market Area, and Industry Position
Table 65. Qizheng OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 66. Qizheng OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Qizheng Company Profile and Main Business
Table 68. Qizheng Recent Developments
Table 69. Endo Company Information, Head Office, Market Area, and Industry Position
Table 70. Endo OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 71. Endo OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Endo Company Profile and Main Business
Table 73. Endo Recent Developments
Table 74. Huarun 999 Company Information, Head Office, Market Area, and Industry Position
Table 75. Huarun 999 OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 76. Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Huarun 999 Company Profile and Main Business
Table 78. Huarun 999 Recent Developments
Table 79. GSK Company Information, Head Office, Market Area, and Industry Position
Table 80. GSK OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 81. GSK OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. GSK Company Profile and Main Business
Table 83. GSK Recent Developments
Table 84. Haw Par Company Information, Head Office, Market Area, and Industry Position
Table 85. Haw Par OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 86. Haw Par OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Haw Par Company Profile and Main Business
Table 88. Haw Par Recent Developments
Table 89. Nichiban Company Information, Head Office, Market Area, and Industry Position
Table 90. Nichiban OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 91. Nichiban OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Nichiban Company Profile and Main Business
Table 93. Nichiban Recent Developments
Table 94. Laboratoires Genevrier Company Information, Head Office, Market Area, and Industry Position
Table 95. Laboratoires Genevrier OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 96. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Laboratoires Genevrier Company Profile and Main Business
Table 98. Laboratoires Genevrier Recent Developments
Table 99. BLUE-EMU Company Information, Head Office, Market Area, and Industry Position
Table 100. BLUE-EMU OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 101. BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. BLUE-EMU Company Profile and Main Business
Table 103. BLUE-EMU Recent Developments
Table 104. IBSA Group Company Information, Head Office, Market Area, and Industry Position
Table 105. IBSA Group OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 106. IBSA Group OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. IBSA Group Company Profile and Main Business
Table 108. IBSA Group Recent Developments
Table 109. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 110. Pfizer OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 111. Pfizer OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Pfizer Company Profile and Main Business
Table 113. Pfizer Recent Developments
Table 114. Performance Health Company Information, Head Office, Market Area, and Industry Position
Table 115. Performance Health OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 116. Performance Health OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Performance Health Company Profile and Main Business
Table 118. Performance Health Recent Developments
Table 119. Actavis Company Information, Head Office, Market Area, and Industry Position
Table 120. Actavis OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 121. Actavis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Actavis Company Profile and Main Business
Table 123. Actavis Recent Developments
Table 124. Teikoku Seiyaku Company Information, Head Office, Market Area, and Industry Position
Table 125. Teikoku Seiyaku OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 126. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Teikoku Seiyaku Company Profile and Main Business
Table 128. Teikoku Seiyaku Recent Developments
Table 129. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 130. Novartis OTC Transdermal Analgesic Patches Models, Specifications, and Application
Table 131. Novartis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Novartis Company Profile and Main Business
Table 133. Novartis Recent Developments
List of Figures
Figure 1. OTC Transdermal Analgesic Patches Picture
Figure 2. Global OTC Transdermal Analgesic Patches Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global OTC Transdermal Analgesic Patches Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China OTC Transdermal Analgesic Patches Consumption Value, (US$ million) & (2018-2029)
Figure 6. China OTC Transdermal Analgesic Patches Sales Quantity (K Units) & (2018-2029)
Figure 7. China OTC Transdermal Analgesic Patches Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China OTC Transdermal Analgesic Patches Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China OTC Transdermal Analgesic Patches Market Share of Global, 2018-2029
Figure 10. Global OTC Transdermal Analgesic Patches Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China OTC Transdermal Analgesic Patches Key Participants, Market Share, 2022
Figure 12. Global OTC Transdermal Analgesic Patches Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global OTC Transdermal Analgesic Patches Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global OTC Transdermal Analgesic Patches Production Market Share & Forecast by Region, 2018-2029
Figure 15. OTC Transdermal Analgesic Patches Industry Chain
Figure 16. OTC Transdermal Analgesic Patches Procurement Model
Figure 17. OTC Transdermal Analgesic Patches Sales Model
Figure 18. OTC Transdermal Analgesic Patches Sales Channels, Direct Sales, and Distribution
Figure 19. Lidocaine Patches
Figure 20. Diclofenac Patches
Figure 21. Indomethacin Patches
Figure 22. Counter-Irritant Patches
Figure 23. Others
Figure 24. By Type, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Pharmacy
Figure 30. Clinic
Figure 31. Others
Figure 32. By Application, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029
Figure 39. North America OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022
Figure 41. Europe OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022
Figure 43. Asia Pacific OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022
Figure 45. South America OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022
Figure 47. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 54. China OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 66. India OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|